InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Tung Roger D, Chairman & CEO. Director active across 1 company, notably Concert Pharmaceuticals, INC.. In total, 9 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €100k. Activity tracked since 13 December 2021. The latest transaction was filed on 6 January 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Tung Roger D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
756,427 sharesCommon StockSEC:0001209191-23-016169:0
9,240 shares@ US$7.2444.8% of flowCommon StockSEC:0001209191-23-002556:0
13,480 shares@ US$3.0947.0% of flowCommon StockSEC:0001209191-22-010075:0
52,225 sharesCommon StockSEC:0001209191-22-005889:0
7,000 shares0Common StockSEC:0001209191-22-002405:0
6,700 shares@ US$3.5026.5% of flowCommon StockSEC:0001209191-21-069812:0
12,888 sharesCommon StockSEC:0001209191-16-091209:0
12,888 sharesCommon StockSEC:0001209191-16-091209:1
18,000 sharesCommon StockSEC:0001209191-16-091209:2
9 of 9 declarations
About Tung Roger D
Roger D. Tung is the Chief Executive Officer of Concert Pharmaceuticals, Inc. He leads the company in its efforts to develop innovative treatments. His leadership is essential for the strategy and growth of Concert Pharmaceuticals.
